GIA
BNTX icon

Gladstone Institutional Advisory’s BioNTech BNTX Stock Holding History

Gladstone Institutional Advisory’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,547
Closed -$346K – 549
2021
Q2 		$346K Buy
+1,547
New +$292K 0.04% 369

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Gladstone Institutional Advisory's BNTX Position: Q3 2021 in Review

Gladstone Institutional Advisory sold out of BioNTech (BNTX) in Q3 2021, closing a stake of 1,547 shares — an estimated $346K sold.

Gladstone Institutional Advisory first reported a position in BNTX in Q2 2021 and held it in 1 quarter. The position peaked at $346K in Q2 2021. 335 funds tracked by Wall St. Rank hold BNTX as of Q3 2021.

  • Gladstone Institutional Advisory reported no remaining BioNTech position as of Q3 2021 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 1,547 BioNTech shares in Q3 2021, an estimated $346K.
  • Gladstone Institutional Advisory first reported a position in BioNTech in Q2 2021 and held it in 1 quarter.
  • Gladstone Institutional Advisory's BioNTech position peaked at $346K in Q2 2021.
  • 335 funds tracked by Wall St. Rank held BioNTech as of Q3 2021.

Based on Gladstone Institutional Advisory's 13F filing for Q3 2021, filed 15 Nov 2021.